Aethlon Medical(AEMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AEMD Aethlon Medical

Market Closed 09-04 16:00:00 EDT

1.82

-0.11

-5.70%

盘后1.81

-0.01-0.55%

19:57 EDT

High1.82	Low1.70	Vol165.47K
Open1.79	D1 Closing1.93	Amplitude6.22%
Mkt Cap2.92M	Tradable Cap2.91M	Total Shares1.60M
T/O293.48K	T/O Rate10.35%	Tradable Shares1.60M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AEMD","market":"US","secType":"STK","nameCN":"Aethlon Medical","latestPrice":1.82,"timestamp":1788552000000,"preClose":1.93,"halted":0,"volume":165472,"hourTrading":{"tag":"盘后","latestPrice":1.81,"preClose":1.82,"latestTime":"19:57 EDT","volume":9995,"amount":17965.6814,"timestamp":1788566265683,"change":-0.01,"changeRate":-0.005495,"amplitude":0.032967},"delay":0,"changeRate":-0.05699481865284968,"floatShares":1599400,"shares":1604100,"eps":-42.4608,"marketStatus":"Market Closed","change":-0.11,"latestTime":"09-04 16:00:00 EDT","open":1.79,"high":1.82,"low":1.7,"amount":293481.801088,"amplitude":0.062176,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-42.4608,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.93,"preHourTrading":{"tag":"盘前","latestPrice":1.8,"preClose":1.93,"latestTime":"09:28 EDT","volume":18214,"amount":32054.700209,"timestamp":1788528498056,"change":-0.13,"changeRate":-0.067358,"amplitude":0.070052},"postHourTrading":{"tag":"盘后","latestPrice":1.81,"preClose":1.82,"latestTime":"19:57 EDT","volume":9995,"amount":17965.6814,"timestamp":1788566265683,"change":-0.01,"changeRate":-0.005495,"amplitude":0.032967},"volumeRatio":0.017533096537922295,"impliedVol":3.8125,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/AEMD","defaultTab":"news","newsList":[{"id":"2664830033","title":"Aethlon Medical Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2664830033","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664830033?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:06","pubTimestamp":1788257173,"startTime":"0","endTime":"0","summary":"Aethlon Medical announces annual shareholder meetingAethlon Medical will hold its annual shareholder meeting virtually on Oct. 1, 2026.Shareholders will vote on electing five directors, ratifying audi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL4Y3hLN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD","BK4568","BK4583","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663515009","title":"Aethlon Medical Completes Warrant Exercises, Clarifying Capitalization","url":"https://stock-news.laohu8.com/highlight/detail?id=2663515009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663515009?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:51","pubTimestamp":1788184315,"startTime":"0","endTime":"0","summary":"An announcement from Aethlon Medical ( ($AEMD) ) is now available. Aethlon Medical, Inc. reported that, following recent exercises of certain pre-f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-completes-warrant-exercises-clarifying-capitalization?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-completes-warrant-exercises-clarifying-capitalization?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4583","AEMD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663057430","title":"Aethlon Medical Says All Pre-Funded Warrants are Exercised","url":"https://stock-news.laohu8.com/highlight/detail?id=2663057430","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663057430?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182150,"startTime":"0","endTime":"0","summary":"Aethlon Medical says all pre-funded warrants are exercisedAethlon Medical reported all previously outstanding pre-funded warrants were exercised following recent warrant exercises.Common shares outsta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLc5SWhH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","AEMD","BK4583","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660494433","title":"Aethlon Medical: Pre-Revenue Status, Ongoing Cash Burn, and Early Hemopurifier Progress Support Balanced Risk/Reward and Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2660494433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660494433?lang=en_us&edition=fundamental","pubTime":"2026-08-19 03:25","pubTimestamp":1787081120,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Anthony Vendetti has maintained their neutral stance on AEMD stock, giving a Hold rating today. Anthony Vendetti has given his ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/aethlon-medical-pre-revenue-status-ongoing-cash-burn-and-early-hemopurifier-progress-support-balanced-risk-reward-and-hold-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/aethlon-medical-pre-revenue-status-ongoing-cash-burn-and-early-hemopurifier-progress-support-balanced-risk-reward-and-hold-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AEMD","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659193315","title":"Aethlon Medical Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659193315","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659193315?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:54","pubTimestamp":1786658090,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc reports results for the quarter ended June 30 - Earnings SummaryAethlon Medical IncAEMD.OQreported a quarterly adjusted loss of $4.02 per share for the quarter ended June 30, highe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL8N44A2CI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD","BK4568","BK4583","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160781","title":"Aethlon Medical Advances Hemopurifier Trials and Bolsters Liquidity","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160781","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160781?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:01","pubTimestamp":1786654870,"startTime":"0","endTime":"0","summary":"Aethlon Medical ( ($AEMD) ) just unveiled an update. On August 13, 2026, Aethlon Medical reported results for its fiscal first quarter ended June 3...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-advances-hemopurifier-trials-and-bolsters-liquidity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-advances-hemopurifier-trials-and-bolsters-liquidity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AEMD","BK4082","BK4568","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167947","title":"Aethlon Medical Q1 FY27 Net Loss Narrows 12.12% to $1.55 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167947","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167947?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:26","pubTimestamp":1786652764,"startTime":"0","endTime":"0","summary":"Aethlon Medical Q1 FY27 net loss narrows 12.12% to $1.55 millionAethlon Medical posted a net loss attributable to common stockholders of $1.55 million, improving from $1.76 million a year earlier.Oper","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLX1b09:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","AEMD","BK4568","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659039160","title":"Aethlon Medical Fiscal Q1 2027 results: Lower expenses narrow the net loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2659039160","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659039160?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:22","pubTimestamp":1786652525,"startTime":"0","endTime":"0","summary":"Aethlon Medical’s fiscal Q1 2027 results showed operating expenses falling 11.9% to $1.58 million, helping narrow the net loss to $1.55 million from $1.76 million. Basic and diluted loss per share improved to $4.02, though the weighted-average share count increased more than ninefold. Cash stood at $4.93 million on June 30, 2026, and a post-quarter public offering raised about $4.0 million in gross proceeds. Clinically, Aethlon dosed the first participant in the final cohort of its Australian Phase 1 Hemopurifier oncology study, while emphasizing that early biomarker observations remain preliminary.","market":"hk","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock8.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock8.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/earnings/262103672-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4082","BK4568","AEMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659853167","title":"Aethlon Medical Q1 EPS $(4.02) Misses $(0.79) Estimate; Cash & Equivalents $4.9M","url":"https://stock-news.laohu8.com/highlight/detail?id=2659853167","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659853167?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:17","pubTimestamp":1786652221,"startTime":"0","endTime":"0","summary":"Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(4.02) per share which missed the analyst consensus estimate of $(0.79) by 415.38 percent. This is a 90.52 percent increase over losses of $(42.42) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61193470/aethlon-medical-q1-eps-4-02-misses-0-79-estimate-cash-equivalents-4-9m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Aethlon Medical Q1 EPS $(4.02) Misses $(0.79) Estimate; Cash & Equivalents $4.9M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659193629","title":"Aethlon Medical Inc: Q1 EPS of $-4.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2659193629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659193629?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA2D4XW8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","AEMD","BK4583","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162057","title":"Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162057?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA2D4XW8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","BK4082","AEMD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946938","title":"Aethlon Medical Inc Expected to Post a Loss of 78 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946938","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946938?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:23","pubTimestamp":1786483385,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc <AEMD.OQ> expected to post a loss of78cents a share - Earnings PreviewAethlon Medical IncAEMD.OQAEMD.Ois expected to  show no change in quarterly revenue when it reports  results o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N44828G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","AEMD","BK4583","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657541056","title":"Aethlon Medical Schedules Quarterly Results Release, Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2657541056","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657541056?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:04","pubTimestamp":1785931474,"startTime":"0","endTime":"0","summary":"Aethlon Medical schedules quarterly results release, conference callAethlon Medical schedules fiscal Q1 results release for Aug. 13, 2026 at 4:15 p.m. ET.Conference call set for Aug. 13, 2026 at 4:30 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL1wJw3w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","BK4583","AEMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588428","title":"Aethlon Medical trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588428?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:50","pubTimestamp":1785801014,"startTime":"0","endTime":"0","summary":"19:50 EDT Aethlon Medical (AEMD) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aethlon-medical-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aethlon-medical-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4568","BK4583","AEMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656889185","title":"NASDAQ Trade Halt Halt News Pending at 07:50 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2656889185","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656889185?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:50","pubTimestamp":1785801000,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 07:50 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nAQN2MCX7R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD","BK4583","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655657723","title":"Aethlon Medical Effects 1-for-5 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2655657723","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655657723?lang=en_us&edition=fundamental","pubTime":"2026-07-31 20:04","pubTimestamp":1785499452,"startTime":"0","endTime":"0","summary":"Aethlon Medical effects 1-for-5 reverse stock splitAethlon Medical filed to execute a 1-for-5 reverse stock split, effective 10 a.m. ET July 31, 2026.Split-adjusted trading is expected to start Aug. 4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL2znRZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4583","AEMD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651119443","title":"Aethlon Medical Reports Biomarker Shifts in Second Cohort of Hemopurifier Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2651119443","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651119443?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:06","pubTimestamp":1783944378,"startTime":"0","endTime":"0","summary":"Aethlon Medical reports biomarker shifts in second cohort of Hemopurifier cancer trialAethlon Medical reported similar biomarker shifts in cohort 2 of its Australian oncology feasibility study of Hemo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDLbvWcrk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4568","BK4082","AEMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651119696","title":"Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®","url":"https://stock-news.laohu8.com/highlight/detail?id=2651119696","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651119696?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:01","pubTimestamp":1783944060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nTUA1YKWJR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4583","AEMD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649624078","title":"Aethlon Medical Prices $4 Million Offering with Warrants Exercisable at $0.71 on Shareholder Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2649624078","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649624078?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:28","pubTimestamp":1783344512,"startTime":"0","endTime":"0","summary":"Aethlon Medical prices $4 million offering with warrants exercisable at $0.71 on shareholder approvalAethlon Medical priced a follow-on offering with warrants to buy 5,633,009 common shares at an exer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL7fb7Mp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD","BK4568","BK4583","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649624746","title":"Aethlon Medical Announces Pricing of $4.0 Million Follow-on Offering Priced At-the-market Under NASDAQ Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2649624746","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649624746?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:25","pubTimestamp":1783344300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA8MXX2Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4082","BK4583","AEMD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aethlonmedical.com","stockEarnings":[{"period":"1week","weight":-0.2691},{"period":"1month","weight":-0.44},{"period":"3month","weight":-0.8094},{"period":"6month","weight":-0.7859},{"period":"1year","weight":-0.9504},{"period":"ytd","weight":-0.8686}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.360101},{"month":2,"riseRate":0.090909,"avgChangeRate":-0.164148},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.10297},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.093808},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.115037},{"month":6,"riseRate":0.727273,"avgChangeRate":0.120705},{"month":7,"riseRate":0.181818,"avgChangeRate":-0.095517},{"month":8,"riseRate":0.25,"avgChangeRate":-0.090835},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.086784},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.111246},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.001467},{"month":12,"riseRate":0.454545,"avgChangeRate":0.017294}],"exchange":"NASDAQ","name":"Aethlon Medical","nameEN":"Aethlon Medical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aethlon Medical(AEMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Aethlon Medical(AEMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Aethlon Medical,AEMD,Aethlon Medical股票,Aethlon Medical股票老虎,Aethlon Medical股票老虎国际,Aethlon Medical行情,Aethlon Medical股票行情,Aethlon Medical股价,Aethlon Medical股市,Aethlon Medical股票价格,Aethlon Medical股票交易,Aethlon Medical股票购买,Aethlon Medical股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aethlon Medical(AEMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Aethlon Medical(AEMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}